Abstract Cryptococcus gattii is an environmentally occurring pathogen that is responsible for causing cryptococcosis marked by pneumonia and meningoencephalitis in humans and animals. C. gattii can form long-term associations with trees and soil resulting in the production of infectious propagules (spores and desiccated yeast). The ever-expanding number of reports of clinical and environmental isolation of C. gattii in temperate climates strongly imply that C. gattii occurs worldwide. The key ability of yeast and spores to enter, survive, multiply, and exit host cells, and to infect immunocompetent hosts distinguishes C. gattii as a primary pathogen and suggests evolution of C. gattii pathogenesis as a result of interaction with plants and other organisms in its environmental niche. Here we summarize the historical literature on C. gattii and recent literature supporting the worldwide occurrence of the primary pathogen C. gattii.
Introduction
Cryptococcus gattii (formerly C. neoformans var. gattii) was first recognized by its unique cigar-shaped, elongated morphology ( Fig. 1 ) in the cerebral spinal fluid of an infected Congolese boy, and was later raised to species level due to differences from C. neoformans in morphology, biochemical attributes, and molecular sequences [1-4, 5••] . Cryptococcosis is a disease resulting from the inhalation of the infectious propagules of Cryptococcus from the environment. An initial lung infection can be rapidly cleared, progress to fulminant infection, or persist asymptomatically for long periods of time latently and then disseminate through the bloodstream into the brain, causing neurological symptoms, meningoencephalitis, and eventually death if untreated. Studies of virulence in C. gattii have benefitted from comparison with the well-studied sibling species, C. neoformans. Many of the virulence factors of C. neoformans are conserved in C. gattii, including capsule, melanin, and the ability to grow at 37°C, but the mechanisms of regulation are not always conserved [5••, 6, 7] .
Historically, C. gattii was considered endemic in tropical and subtropical regions of the world. However, beginning in 1999, there has been a continuous and expanding outbreak in the temperate region in the Pacific Northwest (PNW). This outbreak was first recognized by the concurrent identification of humans and animals presenting with pneumonia and/or meningoencephalitis in 1999 on Vancouver Island [8, 9] . The infection rate of C. gattii on Vancouver Island between 1999 and 2003 was found to be substantially higher (about nine times) than in Australia, an endemic region for C. gattii [10] . The outbreak in the PNW was preceded many years earlier by a human infection with C. gattii (NIH4440CBS6956/ATCC 32609), which was isolated in the 1970s from the sputum of a patient in Seattle, WA, USA, which lies in close proximity to Vancouver Island, BC, Canada, and shares a similar climate [5••, 11] . Furthermore, prior to the recognition of the outbreak, molecular type VGII was isolated from the environment in the San Francisco area in 1990 (CBS7750) [12] . In 2004, the outbreak expanded beyond Vancouver Island, with cases observed on the Canadian mainland in humans who had not traveled to Vancouver Island or other locations known to be high risk for C. gattii [13] . The outbreak progressed, and starting in 2005/2006, human and animal cases began to be reported in Oregon and Washington [14••] . It is currently unknown how far it will eventually spread, and what barriers may exist to further spread. Monitoring the progression of this outbreak is important for public health officials as well as physicians and veterinarians.
Virulence
Under laboratory conditions, both yeast cells and spores can initiate infection and cause disease in animal models [15, 16] . Due to the smaller size of spores they may be more effectively aerosolized in nature and more efficiently enter the bronchial tubes and alveolar spaces within the lungs [15, 17] . Additionally, spores are implicated in promoting infection and disease development because, in contrast to yeast cells, they do not require opsonization for phagocytosis by macrophages [16] . The ability to persist inside host cells is a key virulence attribute. In an evolutionary sense, this is likely linked to the interaction between Cryptococcus species, its environmental niche, and other organisms (amoeba, nematodes, insects, plants, and other fungi) [18-22, 23•] . However, virulence in the human host entails survival and nonlytic expulsion after phagocytosis by macrophages (vomocytosis) [22, 24, 25] .
Cryptococcus is a facultative intracellular pathogen, and proliferation within macrophages and the formation of tubular mitochondria has been correlated with virulence in the murine and Galleria model systems [26••, 27••] . Increased intracellular proliferation rates have been associated with upregulation in protein degradation and synthesis, carbohydrate metabolism, stress response, nucleotide metabolism, vesicular fusion, and transport [25, 26••] . Fusion of mitochondria results in morphological changes and the appearance of tubular mitochondria, which may protect against cell death and mutations by allowing complementation between mitochondria. Macrophages are implicated in both the dissemination of Cryptococcus from the lungs and the ferrying of Cryptococcus across the blood-brain barrier to the central nervous system [28] . The ability of spores to be more readily phagocytosed may dramatically impact latency and the course of infection.
Molecular Types
Historical perspectives on cryptococcosis due specifically to C. gattii in AIDS patients are restricted because C. gattii and C. neoformans were not previously differentiated. Cryptococcal serotypes were first readily distinguished by agglutination assays into serotypes A, B, C, and D, and later serotypes were associated with C. neoformans (serotype A, D, and AD hybrids) and C. gattii (serotypes B and C) [29] [30] [31] [32] . Canavanine-glycine-bromothymol blue agar is now widely used for initial identification of C. gattii in clinical samples [31, 33, 34] . Genotyping of Cryptococcus species has resulted in major advances in differentiating C. gattii isolates. PCR fingerprinting and amplified fragment length polymorphisms (AFLP) have redefined our understanding of C. gattii. Four molecular types are now recognized: VGI, VGII, VGIII, and VGIV [32, 35, 36, 37•, 38, 39] . C. gattii-C. neoformans hybrids are rare, and obtained only from clinical samples. They are identified as a result of AFLP, and multilocus sequence typing (MLST) analysis (AFLP8 and AFLP9) [40•, 41, 42] . Only VGI and VGII have been associated thus far with the formation of hybrids with C. neoformans [41] [42] [43] .
C. gattii VGI is the most prevalent type of veterinary, clinical, and environmental isolate sampled worldwide. Clinical and veterinary cases associated with C. gattii VGI in The Netherlands, China, Germany, Portugal, France, Italy, PNW, and Eastern USA, combined with the recent documented environmental isolation of VGI from The Netherlands, Spain, Italy, and PNW, strongly suggest a greatly expanded ecological niche of VGI outside the historically endemic regions [44, 45•, 46•, 47•, 48, 49, 50•, 51] . VGII has a more restricted distribution. It is most prominently associated with disease in the PNW and Australia, although it has also been associated with disease in Central and South America, India, Korea, and China [52] [53] [54] [55] [56] [57] . VGI and VGII primarily infect immunocompetent or non-AIDS immunocompromised hosts. C. gattii VGIII and VGIV are associated with immunocompromised AIDS patients, but can also occur in patients with no apparent immune dysfunction [58] [59] [60] . The clinical presence of VGIII is prominent in California, but recent reports from New Mexico suggest that VGIII has established an environmental niche in the Southwestern USA. In stark contrast to the clinical presence of VGI, VGII, and VGIII, only two isolates of C. gattii, CBS7750 (VGII, 1990, San Francisco) and WM161 (VGIII, San Diego), have ever been recovered environmentally from California [32, 61] . In the Southwestern USA, the ecological reservoir(s) of C. gattii remains elusive even with increased environmental sampling [52, 62•, 63••] . Furthermore, VGIII has been associated with sporadic infections in Mexico, Colombia, Brazil, and Korea [32, 52, 59, 64] . Isolation of VGIV is much more sporadic outside Africa, but has been associated with clinical cases in Mexico, Puerto Rico, Brazil, South America, and India [32, 58, 60, 64, 65•, 66] . The sporadic cases of VGIII and VGIV appear to suggest unknown environmental reservoirs, because many of these patients lacked a travel history to known regions of endemic populations of VGIII or VGIV [59, 65•, 67•] .
AFLP and PCR fingerprinting readily became the methods of choice over serotyping due to higher resolution differences observed in C. gattii. The major limitation of PCR fingerprinting and AFLP analysis is that reference strains must always be included because the results are often inconsistent, which can prevent direct comparisons between research groups. Technological advances and the reduced cost of DNA sequencing have led to widespread sequencing and phylogenetic analysis of Cryptococcus. Comparisons between strains are in some cases limited because different laboratories routinely utilize different primer sets. The widespread implementation of MLST analysis of C. gattii has expanded our understanding of its diversity [32, 68, 69] . The proposed consensus MLST scheme for C. neoformans and C. gattii proposed by the International Society for Human and Animal Mycology (ISHAM) recommends the use of seven unlinked loci (CAP59, GPD1, LAC1, PLB1, SOD1, URA5 and IGS1) for all global genotyping [70] . At each locus an allele number is assigned for each unique genetic sequence observed and sequence type (ST) is then assigned based on the combination of alleles at each locus. The allele and sequence type database for C. gattii is maintained and publicly accessible at http://mlst.mycologylab.org/. The MLST approach allows direct comparison of global isolates of Cryptococcus and further substantiates the recognition of the four major molecular types of C. gattii previously recognized by PCR fingerprinting and AFLP analysis. Additional subclades within VGII/AFLP6 (VGIIa/AFLP6a, VGIIb/AFLP6b, VGIIc/AFLP6c), and VGIII (VGIIIa and VGIIIb) [ Although gene synteny appears to be conserved, the mitochondrial genome of C. gattii (34.7 kb) is larger than that of C. neoformans var. neoformans (32 kb) and C. neoformans var. grubii (24 kb) [72, 73, 74•] . A recent mitochondrial hybridization event occurred in the VGI lineage that may reflect hybridization and mitochondrial DNA exchange from VGII to VGI [72, 74•] . Mitochondrial genomes of highly virulent C. gattii strains may be under selection because increased genetic variation was detected in coding regions versus highly conserved intergenic regions as shown by mitochondrial recombination in C. gattii [72, 74•] .
Isolates of VGII and VGIII have been demonstrated to mate in laboratory settings, but viable and fertile progeny are limited [3, 63••] . Genetic rearrangements between the VG types may serve as reproductive barriers and limit productive recombination. Key virulence factors, such as capsule, melanin, and urease, are maintained between C. gattii molecular types, but the regulation of these factors can differ [6] . CAS3 in C. gattii is not linked to capsule size in vitro, in contrast to C. neoformans, but is important for the virulence of both species in vivo [6] . In C. gattii, CAS3 has been found to be upregulated in VGIIa in contrast to VGIIb. Microarray data have identified several key virulence factors upregulated in VGIIa compared to VGIIb that include Cas3, the Map kinase Mpk1 (involved in growth at 37°C), and the laccases Lac1 and Lac2 (involved in melanin synthesis) [6] .
The original description of VGIIa in the PNW suggested that this genotype may be restricted to the ongoing outbreak, but recently a VGIIa strain identical to R265 at 11 MLST loci has been reported from a patient with cerebral cryptoccoma in Japan. The patient had reportedly traveled to Guam and Saipan but had no recent travel history to the USA [76•] . The reservoir and occurrence of VGIIa outside the USA has not been determined, but its isolation from an otherwise healthy Japanese patient suggests that VGIIa may be spreading, or have unknown geographic and environmental reservoirs outside North America.
Byrnes et al. identified a new genotype, VGIIc, as a component of the outbreak expansion in Oregon. VGIIc demonstrated higher virulence similar to that of VGIIa in a murine model [27••] . How the VGIIa genotype evolved is still unknown, but two hypotheses have been advanced. The two divergent genotypes could be siblings from unknown parents, or one isolate (VGIIa) is the progeny of mating between VGIIb and another unknown isolate of the same mating type [71••] . The second hypothesis for the origin of the VGIIa major genotype is that it resulted from oppositesex mating, possibly in South America where MATa strains are more prevalent. There appears to be substantial evidence for recombination occurring in natural populations that suggests the possibility of same-sex mating, opposite-sex mating, or both [27••, 71••, 77, 78•] . This is further substantiated by the collection of spore-sized particles using air samplers in the Vancouver Island region, which may be produced by mating, because formation of spores requires sexual reproduction [75, 79•] . The apparent absence of MATa strains in the outbreak region suggests that the source of the spores, and of the recombination, is likely α-α samesex mating. As a result of extensive environmental sampling in the PNW, one VGIIa α-α diploid strain was recovered, which supports the hypothesis that same-sex mating among C. gattii is contributing to the outbreak [ The origin of VGIIc is not yet understood. Thus far, VGIIc appears to be restricted and has not been isolated from patients outside Oregon or from any environmental sampling. Although the origin of VGIIc is unknown, it could have resulted from a locally derived mutation and recombination event or from a recent introduction event.
The ongoing clinical and environmental sampling and the low cost of whole genome sequencing will facilitate the sequencing of multiple strains as an alternative to MLST analysis. This approach will likely yield further understanding of the relationships between genotype, origin, and virulence of C. gattii [80•] .
Environmental Distribution of C. gattii
Cryptococcosis is caused by pathogenic Cryptococcus species including C. neoformans and C. gattii. Although attention is drawn to Cryptococcus as mammalian pathogens, natural populations occur as part of the environmental flora associated with trees, soil, and bird droppings. These environmental niches serve as avenues of exposure and disease acquisition, because they are essentially reservoirs of the infectious yeast and spore particles. Thus, studying the distribution and pathogenicity of naturally occurring, nonclinical isolates will advance our understanding of Cryptococcus.
Environmental sampling involves gathering debris, decaying wood, and bird droppings, as well as swabbing various plants including, but not limited to, Eucalyptus, Almond, Douglas fir, laurel, and cacti [10, 65•, 81-84] . Using conventional methods involving selective, defined nutrient media in addition to molecular analyses including MLST and AFLP markers, natural populations of C. gattii have been identified in both tropical and temperate regions. The global distribution of the four VG groups within C. gattii is summarized in Table 1 . VGIV is relatively rare in nonclinical environments and most commonly found in sub-Saharan African AIDS patients, but also has been reported from Mexico, Brazil, and Puerto Rico [60, 64, 65 . Very little gene flow has been detected between the populations of different geographic locations or between different host tree species in India, questioning the dissemination of the strains beyond their local niches. Overall, in both Australia and India, a strong clonality has been found in the population structure of VGI as compared to VGII, which shows moderate signs of sexual recombination in Australia [14••, 90] . VGII is very common in the PNW, Australia, and India, and has recently been found in clinical and environmental isolates from Brazil [57, 91] . In Brazil, a greater proportion of isolates (94 %) in the clinical environment have been found to be VGII than VGI (6 %), but the proportion of VGI in nonclinical isolates from soil and bird droppings is 25 %, suggesting a higher virulence of VGII in mammalian hosts [92] .
Taken together, the distribution patterns of VG lineages within C. gattii do not fit what is expected under the "everything is everywhere" hypothesis, but rather provide evidence that the VG types are endemic to specific regions of the world. Such a population structure may not allow frequent gene flow, promoting speciation within C. gattii in nature. Nevertheless, the frequent occurrence of all VG groups except VGIII and VGIV in nonclinical environments warrants further research into the dissemination of these populations as possible sources of infection of mammalian hosts.
AIDS and C. gattii
Prior to the 1950s, the incidence of cryptococcosis was relatively low and most frequently encountered in the tropics. The emergence of AIDS dramatically altered the prevalence of Cryptococcus. In Africa, cryptococcosis is associated with an increased occurrence of meningitis in an unusually young cohort of patients. Increased awareness of cryptococcosis in the Congo River Basin led to the initial identification of cryptococcosis caused by an atypical strain with an elongated morphology later recognized as C. gattii [1, [93] [94] [95] . Today, infections caused by Cryptococcus are recognized as a significant cause of morbidity and mortality in HIV/AIDS patients and are annually responsible for >1,000,000 infections, >620,000 deaths, and up to onethird of all AIDS-associated deaths [96, 97•] . Recent estimates indicate that Cryptococcus is a more prevalent cause of HIV-related mortality in sub-Saharan Africa than tuberculosis [97•] . In other developing countries, Cryptococcus infections are second only to tuberculosis, and the two frequently co-occur in the AIDS population [98, 99] . The endemic, worldwide, environmental prevalence of the closely related varieties or species, C. neoformans var. neoformans and C. neoformans var. grubii, has resulted in their frequent association with AIDS. The proportion of Cryptococcus/AIDS-related infections that are inherently due to C. gattii has only recently been addressed because reporting of Cryptococcus infections and the determination of species is not prevalent worldwide. Retrospective and more recent clinical studies indicate C. gattii-associated disease in AIDS patients is less common than C. neoformans-associated disease, but the actual incidence may depend upon geographic origin, travel, and environmental exposure to the pathogen.
C. gattii causes many fewer infections in AIDS patients than C. neoformans. However, C. gattii is more prevalent than C. neoformans in immunocompetent and apparently healthy individuals. Serotype C, VGIII and VGIV are the most prolific C. gattii types associated with AIDS, but serotype B, VGI, VGII and C. gattii-C. neoformans (VGI/ VNI) hybrids have been sporadically isolated from AIDS patients [41, 42, 63••, 100-103] . In the US, C. gattii molecular type VGIII (12 %) is most prevalent in Californian AIDS patients. In South Africa VGIII (1 %) and VGIV (1 %) are found in AIDS patients [60, 63••, 100, 103, 104] . In sub-Saharan Africa, Botswana, and Malawi, VGIV was prevalent in AIDS patients (13.3 %) [66] . Case reports from other parts of the world (UK, Mexico, and India) also describe C. gattii in HIV-positive individuals [42, [105] [106] [107] .
Long-term outcomes in patients with AIDS and Cryptococcus have improved due to the decreased cost and continual development of antifungal drugs, highly active antiretroviral therapy (HAART), and combination therapy regimens, but unfortunately cryptococcal infections are still common, frequently recur, and remain difficult to cure. Key issues in undeveloped nations include difficulties in managing treatment with amphotericin B, the fact that flucytosine is not available, and that most patients receive only fluconazole, which is fungistatic and not fungicidal, and can lead to drug resistance.
Sexual Cycle of C. gattii C. gattii can reproduce asexually through budding, and sexually through mating between the two mating types (a-α, opposite-sex; Fig. 1 ). However, natural populations of C. gattii predominantly contain strains of the α mating type, limiting the opportunities for opposite-sex mating. This mating type is ubiquitous in all geographic regions, in both clinical and environmental isolates, and in every molecular type within C. gattii (VGI, VGII VGIII, and VGIV). For example, all VGI strains in India and Europe (Spain, Italy, The Netherlands) and VGII strains in the PNW have the mating type α, which is also common in VGIII strains in southern California and Mexico [27••, 50•, 63••, 89]. These observations suggest that C. gattii, like its sibling species C. neoformans, may undergo unisexual mating (α-α). In C. neoformans, similar environmental cues trigger opposite-sex and unisexual mating. Morphological features that distinguish the two types of mating are also known and include fused vs. unfused clamp connections and dikaryotic vs. monokaryotic hyphae ( Table 2 ). Unisexual mating in C. gattii has not yet been described under laboratory conditions; however, indirect evidence has been adduced. For instance, despite phylogenetic incompatibilities, and evidence of clonality, limited but unambiguous evidence of recombination is found in unisexual populations of C. gattii, suggesting that unisexual mating may contribute to generating genotypic diversity in natural populations [108] . Here, we review the recent advances in our understanding of the significance and frequency of opposite-sex and unisexual mating in natural populations and its impact on the pathogenicity of C. gattii.
Frequency of Sex
The recent discovery of a sexual cycle in C. amylolentus indicates that virtually all species of the Cryptococcus sensu stricto clade can undergo sexual reproduction [109••] .
Studies on C. gattii indicate that some strains within a species can show more sexual reproduction in nature than others. For example, strains of the VGIII lineage of C. gattii are highly fertile and produce more abundant spores than VGII strains. VGIII also has a higher genetic diversity, with 13 unique genotypes in southern California, and more instances of recombination than VGII, which has a largely clonal population in the PNW. This discrepancy may reflect either a high frequency of sex in natural populations of VGIII, that VGIII was introduced to the southern California region a long time ago, or both [63••] . Moreover, the VGIIIb subgroup mates more avidly under laboratory conditions and shows more signs of greater recombination than VGIIIa. The largely clonal structure of many populations of C. gattii may suggest either fewer instances of opposite-sex mating relative to asexual reproduction or frequent instances of unisexual mating between closely related or identical isolates in nature. Direct demonstration of unisexual mating in the laboratory would verify the latter possibility.
Lack of allelic exchange between the VG groups based on MLST analyses of about 300 global isolates is indicative of speciation [14••, 71••] . VGI, VGII, VGIII and VGIV are molecularly distinct, and geographically separated, which may limit opportunities for mating. Although hybridization events among C. gattii VG types have been demonstrated in the laboratory, limited evidence exists from nature [3, 110] . Recent MLST analysis suggests that introgression events may have occurred between the VGIIIa and VGIIIb subgroups as indicated by the non-ancestral shared allele of PLB1 [63••] . C. neoformans hybrids with C. gattii VGI, VGII and VGIII also have been reported from clinical isolates, and mating has been demonstrated under laboratory conditions [41, 42, 63••, 111] . It is unclear whether all VG groups are cross-fertile or mate with closely related species since fertility varies widely between isolates.
Consequences of Sex
Among the pathogenic Cryptococcus complex, C. gattii is a robust pathogen of immunocompetent individuals, in contrast to C. neoformans, which is primarily restricted to immunocompromised patients. However, less commonly, infections in apparently healthy individuals by C. neoformans have been reported and some molecular types of C. gattii are more frequently associated with disease in immunocompromised individuals [63••, 112-114] . The changes underlying these host shifts may include rewiring of already existing virulence machinery through sexual recombination. Hence, studying the sexual cycle in C. gattii may be fundamental to understanding the evolution of its pathogenicity. Sexual reproduction could contribute to the pathogenicity of C. gattii by generating genetically diverse progeny (basidiospores) that are also infectious propagules. In addition, spores are resistant to desiccation, readily airborne, easily inhaled, and capable of penetrating the alveoli [115] . In southern California, both mating types are present in VGIII clinical populations, suggesting the possibility for opposite-sex mating in nature [14••] . Several of these isolates were indeed found to be highly fertile in laboratory tests, producing abundant spores. In populations in which only one mating type predominates, unisexual mating may generate similar infectious propagules in C. gattii.
The process of meiotic recombination during mating may bring together useful gene combinations, producing progeny better suited to expand the host range including immunocompetent individuals and temperate regions as implicated in VGII isolates found in the PNW. Clinical isolates of the VGII lineage also require higher concentrations of azole drugs for inhibition and may require more aggressive and longer term treatment [14••, 116] . Sex may also help generate greater variance in virulence characteristics. For example, in the VGIII lineage, which is generally very fertile, frequent recombination may have created larger variation in virulence with some progeny emerging as more virulent and others less virulent. Similarly, the subgroup VGIIIb is more fertile and less virulent than VGIIIa, in both murine models and intracellular proliferation rate assays [63••] . The VGII and VGIIIa genotypes may represent highly virulent sexual progeny whose virulence could be maintained through clonal reproduction. Both VGII and VGIIIa lineages contain isolates almost exclusively of the α mating type. Consequently, unisexual mating may also contribute to maintaining the gene combinations responsible for increased virulence.
Lastly, a direct link between mating and the virulence pathway is possible because the mating type locus (MAT) All α a and α in a 1:1 ratio may directly contribute to regulation of virulence. The MAT locus regulates the response to mating pheromones and subsequent hyphae and basidiospore formation. Previous studies in C. neoformans have shown that congenic strains, which differ only at the MAT locus, differ in virulence, indicating that MAT contributes to pathogenicity of the species [111, [117] [118] [119] . Additional investigations have shown no difference in virulence between strains of opposite mating types, indicating that the influence of MAT depends on genetic background [119] [120] [121] . Virulence is a polygenic trait, and the MAT locus governs virulence in concert with other genes, stressing the importance of genetic background in regulation of virulence. The MAT locus in the VGIII lineage exhibits genomic plasticity including gene rearrangements, truncation, and gene loss [63••] . The observed plasticity may be a direct cause or a consequence of the associated high fertility of VGIII. C. gattii has a bipolar MAT locus similar to its pathogenic sister species, C. neoformans. Studies on closely related nonpathogenic species of Cryptococcus suggest that the transition to bipolarity occurred recently and concomitantly with the emergence of the pathogenic C. neoformans/C. gattii species cluster [109••] . Studying the structure and function of the MAT loci of various clinical and nonclinical isolates and its association with virulence is necessary to establish the role of mating in the regulation of pathogenicity in C. gattii.
Conclusion
Research has demonstrated that C. gattii is more than just an opportunistic pathogen because it harbors distinct mechanisms geared to evade, subvert, and manipulate the host immune system, while maintaining intracellular growth. C. gattii is likely to have a wider geographic distribution than presently appreciated based on the ongoing expansion of clinical and environmental reports worldwide. Historically, the prevalence of C. gattii has been overlooked because most clinical laboratories did not distinguish C. gattii from C. neoformans. Due to the increasing documentation of C. gattii in previously undocumented regions, observed differences in drug sensitivity, and disease outcome, clinicians should pursue species-specific diagnoses in all patients presenting with cryptococcosis. Canavanine-glycinebromothymol blue agar and MLST analyses are quick, inexpensive, and reliable methods of distinguishing C. gattii from C. neoformans and should be incorporated into standard clinical testing procedures for cryptococcosis.
